Schering-Plough Launches Phase III Trials Of Experimental Antiretroviral Vicriviroc
Pharmaceutical company Schering-Plough on Monday announced that it has launched two Phase III trials of its experimental antiretroviral drug vicriviroc, Reuters reports (Pierson, Reuters, 9/17). [click link for full article]
More: continued here
Filed under: Clinical Trials on September 21st, 2007